AEGEA Medical Wraps up $13.3M Venture Round
AEGEA Medical Inc., which is developing a minimally invasive treatment for abnormal uterine bleeding, has sealed $13.3 million in new financing led by Covidien Ventures. Existing investors Alloy Ventures and Delphi Ventures also contributed to the round. As a result of the funding, Amy Belt, a director at Covidien Ventures, joins AEGEA's board. The company is based in Redwood City, Calif.
30 June 2011•3 mins read
